Intranasal Insulin for the Treatment of Mild Cognitive Impairment and Alzheimer Disease Dementia
Release Date:
Interview with Suzanne Craft, PhD, author of Safety, Efficacy, and Feasibility of Intranasal Insulin for the Treatment of Mild Cognitive Impairment and Alzheimer Disease Dementia: A Randomized Clinical Trial
Intranasal Insulin for the Treatment of Mild Cognitive Impairment and Alzheimer Disease Dementia